Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1115 | 984 | 1115 | 1024 | 1487 | 2375 |
Fund Return | 11.45% | -1.55% | 11.45% | 0.81% | 8.26% | 9.04% |
Place in category | 1458 | 1228 | 1458 | 1022 | 781 | 355 |
% in Category | 54 | 43 | 54 | 45 | 46 | 41 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0090841692 | 1.05B | 21.36 | 8.23 | 7.10 | ||
Global Allocation Fund X4 USD | 518.62M | 12.96 | 3.74 | 6.58 | ||
BlackRock Glbl Funds Glbl Alloc E2 | 1.24B | 8.27 | 0.31 | 4.15 | ||
LU0147395726 | 360.38M | 7.46 | -0.44 | 3.38 | ||
Global Allocation Fund J2 USD | 15.65M | 10.71 | 2.55 | 6.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cap Group New Perspective lux ZLgd | 16.16B | 18.28 | 3.62 | 10.80 | ||
Capital Group New Perspective Fuzgu | 16.16B | 16.04 | 2.11 | 10.68 | ||
Capital Group New Perspective Fubu | 16.16B | 15.18 | 1.35 | 9.80 | ||
Capital Group New Perspective Fubdu | 16.16B | 15.20 | 1.35 | 9.80 | ||
Cap Group New Perspective lux C | 16.16B | 17.04 | 2.93 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 7.38 | 428.50 | -0.12% | |
Amazon.com | US0231351067 | 5.07 | 230.71 | +2.11% | |
Boston Scientific | US1011371077 | 4.43 | 100.91 | +2.28% | |
UnitedHealth | US91324P1021 | 4.32 | 524.99 | +2.99% | |
Applied Materials | US0382221051 | 4.27 | 192.87 | +0.43% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review